Profiel
Robert Eberwein worked as a Director of Facilities & Engineering Operations at Catalent Maryland, Inc. from 2007 to 2017.
Prior to that, he was a Diagnostic Reagents Technologist at Becton, Dickinson & Co., Head of GMP Operations at Cambrex Corp., and a Fermentation Specialist at North American Vaccine, Inc. He received an undergraduate degree from Hood College.
Eerdere bekende functies van Robert Eberwein
| Bedrijven | Functie | Einde |
|---|---|---|
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceuticals | Operationeel Directeur | 01-09-2017 |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Corporate Officer/Principal | - |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| CAMBREX CORPORATION | Corporate Officer/Principal | - |
Opleiding van Robert Eberwein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
Cambrex Corp.
Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells vaccines for the prevention of infectious diseases | Health Technology |
Hood College
Hood College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceuticals | Health Technology |
















